
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS
FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents
DiagnosTear Signs Letter of Intent to Advance Commercial Expansion of TeaRx(TM) in India
Safe Supply talks traction, rebrand, first sale
Safe Supply Streaming Co Ltd. Releases Strategic Corporate Update as Commercial Traction, Government Engagement, and Platform Expansion Accelerate
Mindbio launches intoxication detection tech in U.S.
Mindbio Therapeutics begins trading on OTCQB
Apolo V Acquisition Corp. Enters into Definitive Agreement with Telyrx, Inc.
Bionxt talks cladribine preclinical pig study results
Defence Therapeutics talks precision drug delivery
MindBio Lists for Trading on OTCQB Market
BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)
Glass House talks 2026 expansion plans